Recombinant Factor VIII: Began Phase III trial

Baxter Healthcare Corp. (BAX), Deerfield, Ill. Product: Recombinant Factor VIII Business: Blood products/substitutes Therapeutic category: Thrombolysis/Thrombosis, Enzyme replacement Target: Clotting ...